Our Research
TCRW research is shaped by expertise from our five partnering hospitals across Dublin, and our patient representatives and advocacy groups.
A commitment to inclusion, equity and access underpins all our research themes, guiding how we design studies and translate evidence into practice and policy.
Our research themes are interconnected and strengthened by collaboration, innovation and a shared commitment improving outcomes for women and people affected by reproductive disorders.
Publication and Dissemination
A-Z
Baldwin, M. K., et al. (2023). Building the foundation for a community‑generated national research blueprint for inherited bleeding disorders. https://doi.org/10.1080/17474086.2023.2175660
Browning, J., et al. (2024). Membrane‑bound receptor for advanced glycation end products (RAGE) as a biomarker of low‑quality sperm. https://doi.org/10.1093/hropen/hoae064
Crosby, D. A., et al. (2020). Dysregulation of the interleukin‑17A pathway in endometrial tissue from women with unexplained infertility. https://doi.org/10.1093/humrep/deaa111
Fee, N., et al. (2026). Outcomes of adolescents and young adults attending fertility counselling and oocyte cryopreservation prior to gonadotoxic treatment. https://doi.org/10.1007/s10815-026-03889-z
Glover, L. E., et al. (2018). Uterine natural killer cell progenitor populations predict successful implantation in endometriosis‑associated infertility. https://doi.org/10.1111/aji.12817
Giangrazi, F., et al. (2026). Contribution of endometrial microbiome to inflammation‑mediated infertility in women undergoing ART. https://doi.org/10.1093/humrep/deaf252
Lavin, M., et al. (2018). Significant gynecological bleeding in women with low von Willebrand factor levels. https://doi.org/10.1182/bloodadvances.2018017418
O’Donnell, M., et al. (2026). Menstrual outcomes are frequently overlooked in von Willebrand disease trials. https://doi.org/10.1016/j.rpth.2026.106623
Scheres, L. J. J., et al. (2026). Reducing mortality, improving outcomes, and establishing equity for women with classical haematological disease. https://doi.org/10.1016/S2352-3026(26)00079-7
van Galen, K., et al. (2021). European principles of care for women and girls with inherited bleeding disorders. https://doi.org/10.1111/hae.14379
A-Z
Bourke, N. M., et al. (2022). Human IFNε: Spatiotemporal expression, hormone regulation and innate immunity in the female reproductive tract. https://doi.org/10.1172/jci.insight.135407
Dyer, A. H., et al. (2026). Systemic inflammation, delirium and clinical progression in mild‑moderate Alzheimer disease. https://doi.org/10.1016/j.ebiom.2026.106159
Fung, K. Y., et al. (2024). Expression of interferon epsilon in mucosal epithelium is regulated by Elf3. https://doi.org/10.1128/mcb.334-343
Marks, Z. R. C., et al. (2023). Interferon‑ε is a tumour suppressor and restricts ovarian cancer. https://doi.org/10.1038/s41586-023-06441-4
Smith, N., et al. (2022). Defective activation and regulation of type I interferon immunity associated with increasing COVID‑19 severity. https://doi.org/10.1038/s41467-022-34945-7
Ward, M. P., et al. (2021). Procoagulant activity in high‑grade serous ovarian cancer following neoadjuvant chemotherapy. https://doi.org/10.1016/j.thromres.2021.01.012
Kelly, T. E., et al. (2023). Plasminogen activator inhibitor‑1 in high‑grade serous ovarian cancer metastasis and chemotherapy response. https://doi.org/10.3389/fcell.2023.1150991
Norris, L. A., et al. (2020). Thrombogyn score for prediction of venous thromboembolism in gynecologic cancer. https://doi.org/10.1002/rth2.12342
Ibrahim, E., et al. (2021). Extended prophylaxis for venous thromboembolism following surgery for gynaecological cancers. https://doi.org/10.1016/j.tru.2021.100038
A-Z
Antosik‑Parsons, K., et al. (2025). Gender, nation and reproduction after repeal and decriminalisation. https://doi.org/10.1177/07916035251342136
Antosik‑Parsons, K., Conlon, C., & Duffy, D. N. (2025). After the review: What next for Irish abortion services? https://doi.org/10.1177/07916035251360088
Bratt, K., et al. (2026). Early medical abortion in Irish general practice: ADAPT data and telemedicine as routine care. https://doi.org/10.1136/bmjsrh-2026-203296
Conlon, C. (2024). Variants of abortion exceptionalism: mapping adherence to healthcare standards. (Book chapter).
Conlon, C., Antosik‑Parsons, K., & Butler, É. (2025). Experiences of the Irish model of community medical abortion. https://doi.org/10.1080/07907184.2024.2369335
Conlon, C., et al. (2022). Unplanned Pregnancy and Abortion Care (UnPAC) Study. http://www.tara.tcd.ie/handle/2262/101813
Favier, M., & Conlon, C. (2025). Abortion provision in Ireland: implementation and advocacy. https://doi.org/10.1177/07916035251345356
Honey, A., et al. (2025). Supporting parents with disability through occupational therapy. https://doi.org/10.1111/1440-1630.70026
Codd, Y., et al. (2023). Impact of early inflammatory arthritis on parenting roles. https://doi.org/10.1080/09638288.2021.2006745
White, C., et al. (2026). Lived experience of parenting with inflammatory arthritis. (Qualitative evidence synthesis)
Mazhak, I., et al. (2023–2025). Health, stress, anxiety and inequalities among Ukrainian female refugees.
Kennedy, M., et al. (2024–2026). Physical activity, heavy menstrual bleeding, and physiotherapy care for women with inherited bleeding disorders.
Ireland’s Maternity Safety Statements (2026). National model for transparent reporting.
Maternal Safety Comparative Report (2024). Comparative maternal outcomes across Irish units.
Patient Advocacy and Engagement
Patient Advocacy and Engagement will appear here
Patient Advocacy and Engagement will appear here
Patient Advocacy and Engagement will appear here
Clinical Trials Directory
Ongoing and Completed Clinical Trials will appear here
Ongoing and Completed Clinical Trials will appear here
Ongoing and Completed Clinical Trials will appear here